Trial
NCT05475717
A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Collaborators
—
Condition
Contrast-induced Acute Kidney Injury
Intervention
Alprostadil liposome injection
Why stopped
Voluntarily suspended the trial due to strategic adjustments
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-21